天津中新药业集团股份有限公司

Tianjin Zhongxin Pharmaceutical Group Corporation Limited（hereinafter referred to as Zhongxin Pharmaceutical）is a domestic and overseas listed company with green Traditional Chinese Medicine as its core, which integrates production, operation and scientific research. The business covers many fields such as procurement of medicinal herbs, pre-processing of medicinal herbs, extraction of Chinese medicines, production of Traditional Chinese Medicine, sales of Traditional Chinese Medicine, Tianjin regional pharmaceutical commercial logistics, R & D and manufacturing of nutrition and health products. The company has 22 branches, 17 wholly-owned and holding companies, and 6 joint stock companies. Zhongxin Pharmaceutical has 17 dosage forms and 499 registered varieties. There is one national confidential product (Suxiao Jiuxin Wan), 1 national secret products (Ching Wan Hung Ointment), 5 Chinese medicines of protection varieties (Shunaoxin Di Wan, Zhike Chuanbei Pipa Di Wan, Yatongting Di Wan, Tongmai Yangxin Wan, Zilongjin Pian) and 94 exclusive preparations. 75 Traditional Chinese Medicine and chemical drugs, 601 prepared slices of Chinese crude drugs are listed in the National Essential Drugs Directory, and 177 varieties are listed in the National Medical Insurance Drugs Directory. Zhongxin Pharmaceutical main export markets are Southeast Asia, Japan, North America, Australia etc. The “Great Wall Brand” for export products has the history of more than forty years. It enjoys high reputation in overseas market. In 2009, the company introduced the brand “Da Ren Tang” to the international market. Products such as Super Yinchiao Chiehtu Pien, An Gong Niu Huang Wan, Jinqi Jiangtang Pian, Suxiao Jiuxin Wan, Haima Bushen Wan and Zilongjin Pian for cancer treatment, have been registered and sold in more than 10 countries around the world.